Assessment of p53 protein expression in normal, benign, and malignant oral mucosa
- 1 April 1992
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 166 (4) , 389-394
- https://doi.org/10.1002/path.1711660411
Abstract
Recent studies have shown the accumulation of high levels of p53 protein to be associated with malignant disease, within a range of tissues. This paper assesses p53 expression in oral mucosal disease. Biopsies were obtained from a range of oral disorders which included normal, benign, premalignant, and malignant oral tissue. In addition, oral smears were obtained from a limited number of patients with biopsy-proven oral cancer. Expression of the p53 protein was assessed using the polyclonal antibody CM1, together with a standard immunoperoxidase technique. A total of 37 oral cancers were assessed, of which 20 were found to express the p53 protein (54 per cent of cases). The p53 protein was not identified in normal, benign, or premalignant oral mucosa (54 cases). The identification of p53 within biopsies of oral mucosal lesions would appear to correlate with oral malignancy.Keywords
This publication has 36 references indexed in Scilit:
- In situ detection of HPV DNA in oral mucosal lesions. A comparison of two hybridization kitsJournal of Oral Pathology & Medicine, 1991
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitroInternational Journal of Cancer, 1990
- Simultaneous monitoring of P53 protein and dna content of colorectal adenocarcinomas by flow cytometryInternational Journal of Cancer, 1990
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- CANCER OF THE HEAD AND NECK: ARE WE DOING ANY BETTER?The Lancet, 1985